Understand how step therapy affects psoriasis treatment. Learn about the ‘fail first’ process, the impact of treatment delays ...

For some cases of cancer, the starting point of a new treatment is already inside the patient. Cell therapy provides another option for advanced blood cancers that have not responded to other drugs.

Gaining an early understanding of every step in your manufacturing and analytical processes is essential to bringing gene and cell therapies successfully to market. That’s according to Melissa van Pel ...

Gene therapy has the potential to dramatically benefit patients with genetic blood disorders, but a small study on participants in a clinical trial for sickle cell disease suggests that a key process ...

Pharmaceutical companies are shifting from the development of autologous cell therapies to allogeneic cell therapies.

Many therapists recognize dissociation but feel unsure how to treat it. When dissociation is present, standard trauma ...

When proton therapy is first recommended for patients by their oncologist or primary care physician, or when a patient has learned about proton therapy as a treatment option another way, the first ...

With the FDA expecting to approve 10–20 Cell and Gene Therapies (CGTs) annually by 2025, it is evident that the field will continue to hold immense commercial and medical opportunities. To harness ...

This study examined the impact of a restructured prior authorization process on the delivery of PBT at a proton therapy center. Redesign of a prior authorization process at a proton therapy center was ...

The country’s experiment with psychedelic medicine has led to positive outcomes, psychiatrists say, but also highlights the ...